SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-070621
Filing Date
2022-03-09
Accepted
2022-03-09 16:36:24
Documents
14
Period of Report
2022-03-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d286542d8k.htm   iXBRL 8-K 26890
2 EX-99.1 d286542dex991.htm EX-99.1 13089
6 GRAPHIC g286542g0308171538078.jpg GRAPHIC 4509
  Complete submission text file 0001193125-22-070621.txt   173555

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20220309.xsd EX-101.SCH 2881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20220309_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20220309_pre.xml EX-101.PRE 11278
8 EXTRACTED XBRL INSTANCE DOCUMENT d286542d8k_htm.xml XML 3414
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 22725846
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences